M, C., R, G., AJ, S., R, A., A, R., A, A., . . . J, M. (2026). Antibiotic-associated dysbiosis and bispecific antibody outcomes in multiple myeloma. Journal for immunotherapy of cancer, 14(3), . https://doi.org/10.1136/jitc-2025-014224
Chicago Style (17th ed.) CitationM, Corona, et al. "Antibiotic-associated Dysbiosis and Bispecific Antibody Outcomes in Multiple Myeloma." Journal for Immunotherapy of Cancer 14, no. 3 (2026). https://doi.org/10.1136/jitc-2025-014224.
MLA (9th ed.) CitationM, Corona, et al. "Antibiotic-associated Dysbiosis and Bispecific Antibody Outcomes in Multiple Myeloma." Journal for Immunotherapy of Cancer, vol. 14, no. 3, 2026, https://doi.org/10.1136/jitc-2025-014224.
Warning: These citations may not always be 100% accurate.